Gapping down
In reaction to disappointing earnings/guidance: RARE -19.7%,
LPSN -15.1%,
RAX -14.5%,
ATHX -13.7%,
DEPO -10.7%,
CLNE -9.5%,
MTZ -7.6%,
YY -7.5%,
IPXL -7%,
UNIS -6.6%,
PAH -5.4%,
AKAO -5.2%,
ARWR -4.5%,
LDR -3.9%,
PBYI -3.5%,
OME -3.4%,
GPS -3.4%,
JOBS -3.3%,
CDTI -3.3%,
JGW -2.9%,
PVA -2.9%,
OPK -2.9%,
CRCM -2.8%,
XONE -2.7%,
PME -2.7%,
HALO -2.4%,
EGRX -2.3%,
ZGNX -2.2%,
KMDA -2%,
UNXL -1.7%,
DRNA -1.6%,
MR -1.1%,
MBI -1.1%,
TWER -1.1%,
TEP -1%,
GBDC -0.9%,
FXEN -0.9%,
ACM -0.8%,
STRI -0.8%,
IMOS -0.7%,
APP -0.5%
M&A news: VZ -0.9% (acquired by AOL for $50 per share, or ~$4.4 bln)
Select Airline related names showing weakness: DAL -1.3%,
ALK -4.3%,
TAL -1.9%, UAL -1.5%, LUV -1.1%.
Other news: NOR -23% ( announces a 22.84 mln share, secondary common stock offering, by selling stockholders affiliated with Apollo Global Management ),
NLNK -20.5% ( IMPRESS Phase 3 pancreatic cancer trial with Algenpantucel-L to continue following second interim analysis ),
MTZ -7.6% (discloses a delay in filing its Form 10-Q),
IPXL -7% ( FDA performs GMP and pre-approval inspections of co's Hayward Facility),
CBPX -6% (announces a secondary offering of 4.6 mln common stock shares by selling stockholders, which the co intends to purchase for ~$20 mln),
XONE -2.7% (reported a delay in filing its form 10-Q for Quarter ending March, 2015),
LL -2.6% (CNBC details news some Lumber Liquiditors (LL) insurers do not want to defend company in lawsuits),
PUK -2.3% (announces that Pierre-Olivier Bouée is to step down as Group Chief Risk Officer),
UAL -1.5% (still checking),
NBG -1.4% (EU mkts lower today, cont uncertainty with Greece default)
Analyst comments: SFUN -3.7% (downgraded to Hold from Buy at Deutsche Bank),
I -2.4% (downgraded to Underweight from Equal-Weight at Morgan Stanley),
POR -1.5% (downgraded to Neutral from Overweight at JP Morgan),
MELI -1.1% (downgraded to Hold at Stifel)